Pediatric Dermatology

National report -- Dermatologists likely will exercise more caution in prescribing the topical calcineurin inhibitors (TCIs) Elidel cream (pimecrolimus, Novartis) and Protopic ointment (tacrolimus, Astellas Pharma) in response to the Food and Drug Administration's decision to add "black box" warnings to these drugs' labels, an expert tells Dermatology Times.

National report -- Economic realities will continue driving dermatologists to add cosmetic services and products to their practices, experts tell Dermatology Times. However, sources say this trend is creating concerns about the specialty's ethics, image and accessibility.

VOIP has improved and become more user-friendly, to the point where "ordinary" computer users rather than just the early adopters are installing and using VOIP software.

The new guidelines that regulate physicians who prescribe isotretinoin for their patients are demanding and time-consuming.

Look at your current operations, the shortcomings of your current records system and your expectations for new hardware and software.

Pigmented lesions such as caf? au lait spots are also difficult to remove permanently. In fact, a significant percentage of children who are treated with lasers, whether it's YAG or 532 pulsed dye laser, actually get worse.

Although cutaneous melanoma is rare in children, congenital nevi are one of several known risk factors for melanoma.

It is a higher-viscosity hyaluronic acid manufactured by Q-Med, the same company that manufacturers Restylane for Medicis. Medicis purchased the marketing rights for Restylane in the United States and invested the time and money to get the filler approved. At some point, Medicis undoubtedly will obtain approval for Perlane and add this to its offerings.

New products in the pipeline will add more versatility to fillers, but until they arrive, Dr. Cohen suggests alternatives such as using a 32-gauge needle to fill in etched-in lines in the nasolabial folds and vertical lip lines.

The unit measurement is made by finding out how much of the toxin is lethal to 50 percent of mice in a study. But that amount may vary when new production processes are introduced.

Harrison Hot Springs, British Columbia ? There have been many advances in laser technology for medical applications, but for the treatment of pediatric skin diseases, dermatologists are still turning to the "tried-and-true" pulsed dye, Q-switched pigment and CO2 lasers.

Dermatologists will inevitably increase compliance among ethnic patients when treating scalp conditions such as seborrheic dermatitis or atopic dermatitis if they inquire about the types of hair products the patient normally uses.

Tucson, Ariz. ? Challenging conventional wisdom about treatment modalities might be considered risky business for some dermatologists, but for Norman Levine, M.D., it just comes naturally.

National report ? More basic research into atopic dermatitis (AD) needs to be conducted to understand the subsets of the condition and to generate new therapies to expand the therapeutic choices for the patient, according to Lawrence Chan, M.D., professor and head of the department of dermatology at the University of Illinois. Specifically, differentiating between "intrinsic" and "extrinsic" AD is critical.

In patients for whom rheumatologists once hoped to achieve 20 percent improvement, Dr. Lisse says that with TNF inhibitors, "We're now looking for 50 or 70 percent, or even remission."

San Francisco ? Treating the 65 and older patient is becoming a growing issue in dermatology. While some 35 million Americans ? about one in every eight people ? are elderly today, the senior population is expected to increase to one in five people, or an estimated 70 million, by 2030, according to Wendy E. Roberts, M.D., a dermatologist in Rancho Mirage and assistant clinical professor of medicine at Loma Linda University Medical School, Loma Linda, Calif.

FDA announced that the two topical eczema drugs must carry boxed warning labels about a possible risk of cancer.

Carefully scrutinized, the evidence does not support an actual malignancy risk.

My electronic world observations were further influenced by experiences while visiting a resident-run dermatology clinic.

Macon, Ga. -- Results of a study conducted by a group of dermatologists here show that sufferers of severe persistent dermatitis may find Xolair (omalizumab) to be more effective than standard treatments.

Washington -- The American Academy of Dermatology and the National Jewish Medical and Research Center have issued statements protesting new "black box" cancer warnings the Food and Drug Administration (FDA) has ordered on two drugs used to treat eczema: Elidel Cream (Novartis ) and Protopic ointment (Astellas Pharma).

This former maximum-security federal penitentiary held such notorious criminals as Al Capone, "Creepy" Carpis and Robert Stroud, the "Birdman of Alcatraz." It was a prison from 1934 to 1963 and reopened in 1972 as a recreation area with a self-guiding trail, cellblock tour, slide show and ranger programs. Wear warm clothes and comfortable shoes. Call (415) 705-5555 for times of departure from Pier 41.

Presently, VistA-Office EHR supports electronic reproductions of paper patient charts, from vital sign entry and viewing to problem list and medication management.

If your life were in jeopardy, wouldn't you get a second opinion? Isn't your financial life important as well?

CTCL can look like atypical eczema or atypical psoriasis and it can be treated as such long before it is accurately identified.

The "vaccine" approach of customizing the intervention to the patient is antithetical to the blockbuster mentality of much of the pharmaceutical industry.

Portland, Ore. - Recently concerns have arisen regarding chronic use of the calcineurin inhibitors, Elidel cream (Novartis) and Protopic ointment (Astellas), in treating atopic dermatitis because of their potential association with infection and malignancy.

Las Vegas — Treating difficult eczema cases requires starting with the basics and advancing to approaches such as combination therapies and compounded prescriptions when needed, according to an expert.

Pressure is building in Washington to move forward with the federal government's proposed pay-for-performance Medicare reimbursement program.

This time during her physical examination, the patient was certain that she was touched inappropriately.